申请人:Babu Yarlagadda S.
公开号:US20120149662A1
公开(公告)日:2012-06-14
The invention provides compounds of formula (I):
or a salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of formula (I), processes for preparing compounds of formula (I), intermediates useful for preparing compounds of formula (I) and therapeutic methods for suppressing an immune response or treating cancer or a hematologic malignancy using compounds of formula (I).
本发明提供了以下式子(I)的化合物或其盐,如本文所述。本发明还提供了包含式子(I)化合物的制药组合物,制备式子(I)化合物的方法,用于制备式子(I)化合物的中间体以及使用式子(I)化合物抑制免疫反应或治疗癌症或血液恶性肿瘤的治疗方法。